Phase II Study of Capecitabine and Weekly Docetaxel Followed by Capecitabine Maintenance for Patients With Metastatic Breast Carcinoma

NCT00225056 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

43

Enrollment

OTHER

Sponsor class

Stopped Terminated due to lack of accrual

Conditions

Metastatic Breast Cancer

Interventions

DRUG: docetaxel and capecitabine

Sponsor

Oncology Specialties, Alabama